medigraphic.com
ISSN 0016-3813 (Print)

2004, Number 3

<< Back Next >>

Gac Med Mex 2004; 140 (3)

Abnormal Pre-Surgical Tests and Their Association with Tramp-Surgical Hemorrhagic Complication in Elective Surgery.

Durán-Nah JJ, Aké-Poot LA, Gómez-Vázquez C, Kim-Barrera RE, De la Cruz-Muñoz M, Moscoso-González P, Rodríguez-Burían A

Language: Spanish
References: 23
Page: 281-288
PDF size: 66.34 Kb.


ABSTRACT

Main objective: To determine whether abnormal preoperative coagulation tests (PCT) are related to trans-surgical bleeding complication (TSBC) during elective surgical procedures. Material and methods. Adult patients, undergone some elective surgical procedure in a tertiary care medical center, in Merida, Yucatan, Mexico in whom TSBC was looked for, were selected in a non-random fashion and included. TSBC was considered when bleeding in the surgical bed was ≥: 300ml. Prothrombin time (PT) and partial thromboplastin time (PTT) were the PCT measured and compared against TSBC. To analyze data, inferential statistics was used. Results:Eighty four males (49%) and 86 females (51%), were included. PT, PTT or both were requested to 100% of the them. PT was prolonged in 26 (15%), and PTT was prolonged in 14 (8%) patients. TSBC was documented in 30 patients (18%), although among those with and without bleeding, neither PT averages difference (P=0.76), nor PTT averages difference (P=0.83), were statistically significant. In comparing TSBC and its relationship to abnormal PCT, again neither PT nor PTT were associated with bleeding (Fisher´s exact tests for each: P= 0.41 and P= 1.0, respectively). Conclusion: In this sample, abnormal PCT were not associated with TSBC.


REFERENCES

  1. Griner PF, Liptzin B. Use of the laboratory in a teaching hospital. Ann Intern Med 1971:75:157-63.

  2. Schroeder SA, O´Leary DS. Differences in laboratory use and length of stay between university and community hospitals. J Med Educ 1977;52:418-20.

  3. Roath S, Francis JL. Normal blood coagulation, fibrinolysis, and natural inhibitors of coagulation. Int Anesthesiol Clin 1985;23(2):23-35.

  4. Moir DJ. Investigation of bleeding disorders. Int Anesthesiol Clin 1985;23(2):37-47.

  5. Eisenberg JM, Clarke JR, Sussman SA. Prothrombin and partial thromboplastin times as preoperative screening tests. Arch Surg 1982;117:48-51.

  6. Erban SB, Kinman JL, Sanford Schwartz J. Routine use of the prothrombin and partial thromboplastin times. JAMA 1989;262:2428-32.

  7. Robbins JA, Rose SD. Partial thromboplastin time as screening test. Ann Intern Med 1979;90:796-7.

  8. Kozak EA, Brath LK. Do screening coagulation tests predict bleeding in patients undergoing fiberoptic bronchoscopy with biopsy? Chest 1994;106:703-5.

  9. Srámek A, Eikenboom JCJ, Briët E, Vandenbroucke JP, Rosendaal FR. Usefulness of patient interview in bleeding disorders. Arch Intern Med 1995;155:1409-15.

  10. El concepto de buena salud. Salud Pub Mex 1990;32:245-7. 11. Ruiz-De Chávez M, Martínez-Narváez G, Calvo-Ríos JM, Aguirre-Gas H, Arango-Rojas R, Lara-Carreño R, et al. Bases para la evaluación de la calidad de la atención en las unidades médicas del sector salud. Salud Pub Mex 1990;32:156-69.

  11. Arredondo A, Damián T, De Icaza E. Una aproximación al estudio de costos del servicios de salud en México. Salud Pub Mex 1995;37:437-45.

  12. Arredondo A, Damián T. Costos económicos en la producción de servicios de salud: del costo de los insumos al costo del manejo de casos. Salud Pub Mex 1997;39:117-24.

  13. Conn RB. Clinical laboratories. profit center, production industry or patientcare resource? N Engl J Med 1978;298:422-7.

  14. Blery C, Szatan M, Fourgeaux B, Charpak Y, Darne B, Chastang CL. Evaluation of a protocol for selective ordering of preoperative tests. Lancet 1986;1:139-41.

  15. Tabas GH, Vanek MS. Is routine laboratory testing a thing of the past? Postgrad Med 1999;105:213-20.

  16. Suchman AL, Griner PF. Diagnostic uses of the activated partial thromboplastin time and prothrombin time. Ann Intern Med 1986;104:810-6.

  17. Kitchens CS. Preoperative PTs, PTTs, cost-effectiveness, and health care reform. Radical changes that make good sense. Chest 1994;106:661-2.

  18. Suchman AL, Mushlin AI. How well does the activated partial thromboplastin time predict postoperative hemorrhage? JAMA 1986;256:750-3.

  19. Myers ER, Clarke-Pearson DL, Olt GJ, Soper JT, Berchuck A. Preoperative coagulation testing on a gynecologic oncology service. Obstet Gynecol 1994;83:438-44.

  20. Wojtkowski TA, Rutledge JC, Matthews DC. The clinical impact of increased sensitivity PT and APTT coagulation assays. Am J Clin Pathol 1999;112:225-32.

  21. McVay PA, Toy PTCY. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion 1991;31:164-71.

  22. McVay PA, Toy PTCY. Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities. Am J Clin Pathol 1990;94:747-53.

  23. Silverman SG, Mueller PR, Pfister RC. Hemostatic evaluation before abdominal interventions: an overview and proposal. AJR 1990;154:233-8.




2020     |     www.medigraphic.com